Skip to content
10-Q

Quarterly Report

Monte Rosa Therapeutics, Inc. GLUE

0001193125-25-268045

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 65.12M sh
Shares Diluted Q3 2025 · Sep 30, 2025 82.4M sh
Shares Diluted Q3 2025 · Sep 30, 2025 82.94M sh
Shares Diluted Q3 2025 · Sep 30, 2024 82.01M sh
Shares Diluted Q3 2025 · Sep 30, 2024 71.17M sh
Dividends Paid Q3 2025 · Sep 30, 2025 $0
Capex Q3 2025 · Sep 30, 2025 $3.93M
Capex Q3 2025 · Sep 30, 2024 $3.81M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $20.22M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$86.93M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $208.34M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $224.25M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $125.58M
Stockholders Equity Q3 2025 · Sep 30, 2025 $245.84M
Stockholders Equity Q3 2025 · Jun 30, 2025 $268.08M
Stockholders Equity Q3 2025 · Mar 31, 2025 $275.16M
Stockholders Equity Q3 2025 · Dec 31, 2024 $222.94M
Stockholders Equity Q3 2025 · Sep 30, 2024 $205.46M
Stockholders Equity Q3 2025 · Jun 30, 2024 $224.67M
Stockholders Equity Q3 2025 · Mar 31, 2024 $152.52M
Stockholders Equity Q3 2025 · Dec 31, 2023 $179.25M
Current Liabilities Q3 2025 · Sep 30, 2025 $61.44M
Current Liabilities Q3 2025 · Dec 31, 2024 $156.95M
Total Liabilities Q3 2025 · Sep 30, 2025 $214M
Total Liabilities Q3 2025 · Dec 31, 2024 $215.8M
Current Assets Q3 2025 · Sep 30, 2025 $401.82M
Current Assets Q3 2025 · Dec 31, 2024 $377.44M
Total Assets Q3 2025 · Sep 30, 2025 $459.84M
Total Assets Q3 2025 · Dec 31, 2024 $438.73M
Sga Expense Q3 2025 · Sep 30, 2025 $9.07M
Sga Expense Q3 2025 · Sep 30, 2025 $25.86M
Sga Expense Q3 2025 · Sep 30, 2024 $8.13M
Sga Expense Q3 2025 · Sep 30, 2024 $26.39M
Rd Expense Q3 2025 · Sep 30, 2025 $36.68M
Rd Expense Q3 2025 · Sep 30, 2025 $99.52M
Rd Expense Q3 2025 · Sep 30, 2024 $27.62M
Rd Expense Q3 2025 · Sep 30, 2024 $82.7M
Net Income Q3 2025 · Sep 30, 2025 −$27.08M
Net Income Q3 2025 · Sep 30, 2025 $7.51M
Net Income Q3 2025 · Jun 30, 2025 −$12.3M
Net Income Q3 2025 · Mar 31, 2025 $46.89M
Net Income Q3 2025 · Sep 30, 2024 −$23.86M
Net Income Q3 2025 · Sep 30, 2024 −$86.14M
Net Income Q3 2025 · Jun 30, 2024 −$30.31M
Net Income Q3 2025 · Mar 31, 2024 −$31.97M
Operating Income Q3 2025 · Sep 30, 2025 −$32.98M
Operating Income Q3 2025 · Sep 30, 2025 −$4.49M
Operating Income Q3 2025 · Sep 30, 2024 −$26.53M
Operating Income Q3 2025 · Sep 30, 2024 −$94.12M
Revenue Q3 2025 · Sep 30, 2025 $12.77M
Revenue Q3 2025 · Sep 30, 2025 $120.89M
Revenue Q3 2025 · Sep 30, 2024 $9.22M
Revenue Q3 2025 · Sep 30, 2024 $14.98M